Dear Corrections Colleagues,
As we reflect on the year that is slipping away, one thing is clear -- it was not boring. For those of us involved with the management of infections in our prisons and jails 2006 brought much for us to consider (and lots for us at IDCR to cover) including the Institute of Medicine report on research in prisons, the investigation of the transmission of HIV infection within the Georgia Department of Corrections reported in the MMWR, new CDC recommendations on screening for HIV infection, updated guidelines on initial antiretroviral therapy, the approval of a new HIV protease inhibitor and a vaccine for human papilloma virus and the brisk spread of community acquired MRSA. All of this in addition to our usual coverage of conferences, our interviews with experts and IDCR's symposium at the NCCHC conference.
The past 12 months have also seen some changes here at IDCR. The newsletter is now independent of Brown University. Further, we have developed close ties with the American Academy of HIV Medicine (AAHIVM), and we have expanded to include additional content with each issue. Reflecting on our achievements this year, I can only be proud of our staff, board and authors. Our Managing Editor, Elizabeth Closson, in particular, has been essential to getting the newsletter to you every month.
Since becoming Chief Editor, my goal has been to produce a newsletter readers would want to read and keep handy for future reference. The IDCR coverage of the management of depression in the setting of HIV, tuberculosis, hepatitis B virus and infection control are examples of issues that clinicians within and outside of corrections continue to find useful.
In this month's issue, we continue to strive to keep you informed. Our interview with the CDC's Dr. Richard Wolitski provides an in-depth look at an important HIV/STD prevention trial conducted in four state prisons and highlights the challenges we continue to face in trying to reduce risky behaviors. As we increasingly rely on HIV resistance testing, we have included answers to some of the most commonly asked questions regarding drug resistance and try to un-code the mystery surrounding resistance.
At the cusp of 2007, we are working to create a line-up of issues that will continue to be useful and informative. One thing I can promise, it won't be boring.
David Alain Wohl, M.D.
Associate Professor of Medicine
University of North Carolina
AIDS Clinical Research Unit